UK Government Launches Review of Palantir's £330M NHS Contract

The UK government has formally announced a comprehensive review of its contract with Palantir Technologies Inc. (NASDAQ:PLTR) to provide data services to the National Health Service (NHS), valued at £330 million ($441 million).

Details of the Review

According to a Reuters report on June 9, the review will cover all aspects of the contract between the NHS and Palantir, including data privacy compliance and cost-effectiveness. The report noted that political pressure is mounting on ministers to scrutinize the agreement.

Company's Stance

Palantir has not yet issued an official statement regarding the review. However, the company has previously affirmed its commitment to privacy and security standards in handling NHS data.

Precedents and Context

This is not the first time Palantir's NHS contract has faced criticism; privacy advocacy groups have raised concerns about data protection. Nevertheless, the government has defended the contract as essential for improving healthcare efficiency.

Potential Financial Impact

If the review results in contract cancellation or modification, it could negatively impact Palantir's European revenue. However, the contract represents a relatively small portion of the company's total revenue, which was $2.2 billion in 2025.